124 related articles for article (PubMed ID: 23432215)
1. Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort study.
Schubert-Fritschle G; Schlesinger-Raab A; Hein R; Stolz W; Volkenandt M; Hölzel D; Engel J
Int J Dermatol; 2013 Jun; 52(6):693-704. PubMed ID: 23432215
[TBL] [Abstract][Full Text] [Related]
2. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in localised malignant melanoma.
Schlesinger-Raab A; Schubert-Fritschle G; Hein R; Stolz W; Volkenandt M; Hölzel D; Engel J
Ann Oncol; 2010 Dec; 21(12):2428-2435. PubMed ID: 20494965
[TBL] [Abstract][Full Text] [Related]
4. Baseline psychosocial predictors of survival in localized melanoma.
Lehto US; Ojanen M; Dyba T; Aromaa A; Kellokumpu-Lehtinen P
J Psychosom Res; 2007 Jul; 63(1):9-15. PubMed ID: 17586333
[TBL] [Abstract][Full Text] [Related]
5. Quality of life issues in nonmetastatic skin cancer.
Burdon-Jones D; Thomas P; Baker R
Br J Dermatol; 2010 Jan; 162(1):147-51. PubMed ID: 19796177
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparison.
Engel J; Schlesinger-Raab A; Emeny R; Hölzel D; Schubert-Fritschle G
Int J Behav Med; 2014 Jun; 21(3):478-86. PubMed ID: 23897272
[TBL] [Abstract][Full Text] [Related]
7. The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers.
Burdon-Jones D; Gibbons K
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1109-13. PubMed ID: 22909179
[TBL] [Abstract][Full Text] [Related]
8. Up-to-date results on survival of patients with melanoma in Germany.
Eisemann N; Jansen L; Holleczek B; Waldmann A; Luttmann S; Emrich K; Hauschild A; Brenner H; Katalinic A;
Br J Dermatol; 2012 Sep; 167(3):606-12. PubMed ID: 22564081
[TBL] [Abstract][Full Text] [Related]
9. What are the pertinent quality-of-life issues for melanoma cancer patients? Aiming for the development of a new module to accompany the EORTC core questionnaire.
Winstanley JB; White EG; Boyle FM; Thompson JF
Melanoma Res; 2013 Apr; 23(2):167-74. PubMed ID: 23358427
[TBL] [Abstract][Full Text] [Related]
10. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
12. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording].
Lehnert M; Eberle A; Hentschel S; Katalinic A; Kieschke J; Schmidtmann I; Schubert-Fritschle G; Stegmaier C; Hense HW
Gesundheitswesen; 2005 Oct; 67(10):729-35. PubMed ID: 16235142
[TBL] [Abstract][Full Text] [Related]
13. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
14. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.
Chen T; Bertenthal D; Sahay A; Sen S; Chren MM
Arch Dermatol; 2007 Nov; 143(11):1386-92. PubMed ID: 18025362
[TBL] [Abstract][Full Text] [Related]
15. Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort.
Moock J; Friedrich N; Völzke H; Spielhagen C; Nauck M; Koltowska-Häggström M; Buchfelder M; Wallaschofski H; Kohlmann T
Growth Horm IGF Res; 2011 Oct; 21(5):272-8. PubMed ID: 21865066
[TBL] [Abstract][Full Text] [Related]
16. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
[TBL] [Abstract][Full Text] [Related]
17. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
18. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients.
Lehto US; Ojanen M; Kellokumpu-Lehtinen P
Ann Oncol; 2005 May; 16(5):805-16. PubMed ID: 15817599
[TBL] [Abstract][Full Text] [Related]
19. Population-based incidence rates of malignant melanoma of the vulva in Germany.
Stang A; Streller B; Eisinger B; Jöckel KH
Gynecol Oncol; 2005 Jan; 96(1):216-21. PubMed ID: 15589604
[TBL] [Abstract][Full Text] [Related]
20. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
